Latest news and press releases about Baird Medical Investment Holdings Limited (BDMD): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions.
Price
| Price | $1.06 |
| Market Cap | $45M |
| Exchange | NASDAQ |
| Country | CN |
Valuation Ratios
| Price / Book | 1.25 |
| EV / EBITDA | -4.37 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -48.29% |
| Return on Invested Capital | -26.96% |
| Return on Assets | -21.63% |
| Gross Margin | 85.63% |
| Operating Margin | -58.52% |
| Net Margin | -65.20% |
Related companies: BDSX · BEAT · CTSO · ECOR · FGEN · ICCM · NMTC
Explore sector: Healthcare · Medical - Devices
More sections of BDMD: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks